Marcus Westerberg

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Ingår i Journal of the National Cancer Institute, s. 1142-1150, 2025

• DOI för Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i The Journal of the National Comprehensive Cancer Network, 2025

• DOI för Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Ingår i European Urology Open Science, s. 1-9, 2026

• DOI för Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Ladda ner fulltext (pdf) av Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 282-288, 2026

• DOI för Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

First-Round Fecal Immunochemical Test Concentration Predicts Colorectal Cancer and Advanced Neoplasia in Second-Round Screening

Sekiguchi, Masau; Westerberg, Marcus; Lowbeer, Christian; Blom, Johannes et al.

Ingår i American Journal of Gastroenterology, s. 1484-1491, 2026

• DOI för First-Round Fecal Immunochemical Test Concentration Predicts Colorectal Cancer and Advanced Neoplasia in Second-Round Screening

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Ingår i European Urology Open Science, s. 1-9, 2026

• DOI för Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Ladda ner fulltext (pdf) av Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 282-288, 2026

• DOI för Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

First-Round Fecal Immunochemical Test Concentration Predicts Colorectal Cancer and Advanced Neoplasia in Second-Round Screening

Sekiguchi, Masau; Westerberg, Marcus; Lowbeer, Christian; Blom, Johannes et al.

Ingår i American Journal of Gastroenterology, s. 1484-1491, 2026

• DOI för First-Round Fecal Immunochemical Test Concentration Predicts Colorectal Cancer and Advanced Neoplasia in Second-Round Screening

Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in Sweden

Sekiguchi, Masau; Lowbeer, Christian; Steele, Robert; Blom, Johannes et al.

Ingår i Journal of Medical Screening, s. 29-37, 2026

• DOI för Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in Sweden
• Ladda ner fulltext (pdf) av Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in Sweden

Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer

Ventimiglia, Eugenio; Westerberg, Marcus; Zaurito, Paolo; Miranda, Tiago Bonde et al.

Ingår i Scandinavian journal of urology, s. 22-28, 2026

• DOI för Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer
• Ladda ner fulltext (pdf) av Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer

Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Ventimiglia, Eugenio; Gedeborg, Rolf; Westerberg, Marcus; Zaurito, Paolo et al.

Ingår i Scandinavian journal of urology, s. 64-71, 2026

• DOI för Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results
• Ladda ner fulltext (pdf) av Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Zaurito, Paolo; Gedeborg, Rolf; Garmo, Hans; Ventimiglia, Eugenio et al.

Ingår i Scandinavian journal of urology, s. 51-57, 2026

• DOI för Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study
• Ladda ner fulltext (pdf) av Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Zaurito, Paolo; Westerberg, Marcus; Garmo, Hans; Gedeborg, Rolf et al.

Ingår i BJU International, s. 103-111, 2026

• DOI för Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score
• Ladda ner fulltext (pdf) av Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJU International, s. 629-638, 2026

• DOI för Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Scandinavian journal of urology, s. 93-96, 2025

• DOI för Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Ladda ner fulltext (pdf) av Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Ingår i Journal of the National Cancer Institute, s. 1142-1150, 2025

• DOI för Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Ventimiglia, Eugenio; Gedeborg, Rolf; Orrason, Andri Wilberg; Zaurito, Paolo et al.

Ingår i Scandinavian journal of urology, s. 105-107, 2025

• DOI för A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer
• Ladda ner fulltext (pdf) av A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Westerberg, Marcus; Garmo, Hans; Bonnedahl, Jesper; Eriksson, Marie Hjälm et al.

Ingår i Scientific Reports, 2025

• DOI för Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer
• Ladda ner fulltext (pdf) av Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Ingår i International Journal of Epidemiology, 2025

• DOI för Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Ladda ner fulltext (pdf) av Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Ingår i European Urology Open Science, s. 41-50, 2025

• DOI för Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Ladda ner fulltext (pdf) av Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i The Journal of the National Comprehensive Cancer Network, 2025

• DOI för Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Westerberg, Marcus; Garmo, H.; Ludvigsson, Jonas; Stattin, Pär et al.

Ingår i Clinical Epidemiology, s. 983-993, 2025

• DOI för Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden
• Ladda ner fulltext (pdf) av Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trial

Sekiguchi, Masau; Westerberg, Marcus; Löwbeer, Christian; Forsberg, Anna

Ingår i Gastrointestinal Endoscopy, s. 391-399, 2025

• DOI för Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trial

Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade

Thomsen, Frederik F.; Westerberg, Marcus; Petersson, Rasmus D.; Bak, Rasmine et al.

Ingår i BJU International, s. 760-765, 2025

• DOI för Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade

Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Wilberg Orrason, Andri et al.

Ingår i JAMA Network Open, 2025

• DOI för Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden
• Ladda ner fulltext (pdf) av Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Corsini, Christian; Scilipoti, Pietro; Orrason, Andri Wilberg; Gedeborg, Rolf et al.

Ingår i JNCI Cancer Spectrum, 2025

• DOI för Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance
• Ladda ner fulltext (pdf) av Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study

Wilberg Orrason, Andri; Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf et al.

Ingår i Scandinavian journal of urology, s. 50-58, 2025

• DOI för Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study
• Ladda ner fulltext (pdf) av Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Ingår i Journal of Clinical Epidemiology, 2024

• DOI för Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Ladda ner fulltext (pdf) av Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Corsini, Christian; Bergengren, Oskar; Carlsson, Stefan; Garmo, Hans et al.

Ingår i European Urology Oncology, s. 605-613, 2024

• DOI för Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro; Liedberg, Fredrik; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i Scandinavian journal of urology, s. 98-103, 2024

• DOI för Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study
• Ladda ner fulltext (pdf) av Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Ingår i PLOS ONE, 2024

• DOI för Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield

Bonander, Carl; Westerberg, Marcus; Chauca Strand, Gabriella; Forsberg, Anna et al.

Ingår i JNCI Cancer Spectrum, 2024

• DOI för Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield
• Ladda ner fulltext (pdf) av Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield

Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study

Westerberg, Marcus; Ahlberg, Mats; Wilberg Orrason, Andri; Gedeborg, Rolf

Ingår i Scandinavian journal of urology, s. 207-209, 2024

• DOI för Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study
• Ladda ner fulltext (pdf) av Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study

Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial

Westerberg, Marcus; Eriksson, Julia; Metcalfe, Chris; Löwbeer, Christian et al.

Ingår i Journal of Internal Medicine, s. 187-199, 2024

• DOI för Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial
• Ladda ner fulltext (pdf) av Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial

The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Westerberg, Marcus; Holmberg, Lars; Ekbom, Anders; Metcalfe, Chris et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 503-511, 2024

• DOI för The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial
• Ladda ner fulltext (pdf) av The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Ingår i JAMA Network Open, 2023

• DOI för Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Ladda ner fulltext (pdf) av Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Sekiguchi, Masau; Westerberg, Marcus; Ekbom, Anders; Hultcrantz, Rolf et al.

Ingår i Gastroenterology, s. 293-2950000, 2023

• DOI för Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Design considerations for observational studies of drugs for advanced cancer

Garcia-Albeniz, Xabier; Stattin, Pär; Westerberg, Marcus; Weinrib, Rachel et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 812-815, 2023

• DOI för Design considerations for observational studies of drugs for advanced cancer
• Ladda ner fulltext (pdf) av Design considerations for observational studies of drugs for advanced cancer

Estimation in discrete time coarsened multivariate longitudinal models

Westerberg, Marcus

Ingår i Statistical Methods in Medical Research, s. 806-819, 2023

• DOI för Estimation in discrete time coarsened multivariate longitudinal models
• Ladda ner fulltext (pdf) av Estimation in discrete time coarsened multivariate longitudinal models

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Ingår i Journal of Clinical Epidemiology, s. 22-30, 2023

• DOI för Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Ladda ner fulltext (pdf) av Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Stattin, Pär; Westerberg, Marcus; Lissbrant, Ingela Franck; Eriksson, Marie Hjälm et al.

Ingår i Clinical Genitourinary Cancer, s. 1070-107000000000, 2023

• DOI för Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
• Ladda ner fulltext (pdf) av Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Khoshkar, Yashar; Westerberg, Marcus; Adolfsson, Jan; Bill-Axelson, Anna et al.

Ingår i BJUI Compass, s. 173-183, 2022

• DOI för Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
• Ladda ner fulltext (pdf) av Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Ventimiglia, Eugenio; Bill-Axelson, Anna; Adolfsson, Jan; Aly, Markus et al.

Ingår i European Urology Open Science, s. 46-51, 2022

• DOI för Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
• Ladda ner fulltext (pdf) av Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Ingår i Scandinavian journal of urology, s. 169-175, 2022

• DOI för Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Ladda ner fulltext (pdf) av Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Wilberg Orrason, Andri; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan et al.

Ingår i PLOS ONE, 2022

• DOI för Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
• Ladda ner fulltext (pdf) av Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Lycken, Magdalena; Bergengren, Oskar; Drevin, Linda; Garmo, Hans et al.

Ingår i European Urology Open Science, s. 81-87, 2022

• DOI för Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
• Ladda ner fulltext (pdf) av Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Watch out for sticky diagnosis bias in older men with prostate cancer: Editorial comment to “Evidence of overestimating prostate cancer mortality in Estonia: a population-based study by Innos K et al.”

Bergengren, Oskar; Westerberg, Marcus

Ingår i Scandinavian journal of urology, s. 365-366, 2022

• DOI för Watch out for sticky diagnosis bias in older men with prostate cancer: Editorial comment to “Evidence of overestimating prostate cancer mortality in Estonia: a population-based study by Innos K et al.”

Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial

Strömberg, U.; Bonander, C.; Westerberg, Marcus; Levin, L.Å. et al.

Ingår i eClinicalMedicine, 2022

• DOI för Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial
• Ladda ner fulltext (pdf) av Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial

Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study

Sekiguchi, Masau; Westerberg, Marcus; Ekbom, Anders; Hultcrantz, Rolf et al.

Ingår i Journal of Gastroenterology and Hepatology, s. 2120-2130, 2022

• DOI för Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study

Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Forsberg, Anna; Westerberg, Marcus; Metcalfe, Chris; Steele, Robert et al.

Ingår i The Lancet Gastroenterology & Hepatology, s. 513-521, 2022

• DOI för Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Bergengren, Oskar; Westerberg, Marcus; Holmberg, Lars; Stattin, Pär et al.

Ingår i JAMA Network Open, 2021

• DOI för Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
• Ladda ner fulltext (pdf) av Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Simulation model of disease incidence driven by diagnostic activity

Westerberg, Marcus; Larsson, Rolf; Holmberg, Lars; Stattin, Pär et al.

Ingår i Statistics in Medicine, s. 1172-1188, 2021

• DOI för Simulation model of disease incidence driven by diagnostic activity
• Ladda ner fulltext (pdf) av Simulation model of disease incidence driven by diagnostic activity

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Westerberg, Marcus; Franck Lissbrant, Ingela; Damber, Jan Erik; Robinson, David et al.

Ingår i Acta Oncologica, s. 106-111, 2020

• DOI för Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study
• Ladda ner fulltext (pdf) av Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Orrason, Andri Wilberg; Westerberg, Marcus; Garmo, Hans; Lissbrant, Ingela Franck et al.

Ingår i BJU International, s. 142-151, 2020

• DOI för Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Thomsen, Frederik B.; Westerberg, Marcus; Garmo, Hans; Robinson, David et al.

Ingår i PLOS ONE, 2020

• DOI för Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Prostate cancer incidence, treatment and mortality: Empirical longitudinal register-based studies and methods for handling missing data

Westerberg, Marcus

2022

• Ladda ner fulltext (pdf) av Prostate cancer incidence, treatment and mortality: Empirical longitudinal register-based studies and methods for handling missing data

Modelling short and long term consequences of changes in diagnostic activity and treatment

Westerberg, Marcus

2020

• Ladda ner fulltext (pdf) av Modelling short and long term consequences of changes in diagnostic activity and treatment

Nationwide study of time trends in prostate cancer death over two decades

Lycken, Magdalena; Garmo, Hans; Westerberg, Marcus; Axen, Elin et al.

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.